Byetta is a twice-daily, pre-filled injection treatment for type 2 diabetes. It’s effective at both controlling your blood sugar and reducing your appetite.
Order Byetta online for an effective treatment that can help you to manage your condition and your health.
Exenatide. Drugs, [online] 67(6), pp.935–954. Available at:
Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X). Diabetes Care, [online] 36(10), pp.2945–2951. Available at:
We know health, but you know you.
Our experts tell you what’s safe, but you decide what’s best.
Answer a few questions and tell us about yourself. Get tailored advice from our clinicians so you can choose better.
Choose your treatment and how often you have it delivered.
We know things change. It’s the nature of life. We’ll check in regularly to make sure your treatment is still right for you.
Pause. Change. Skip. Start again. Any time you like.
Diabetes: Here are some other options.
A unique tablet treatment that can lower your blood sugar and reduce your risk of heart problems.
Generic tablet for type-2 diabetes that increases your basal and meal-time insulin levels.
The daily tablet for diabetes that can also help with heart problems.
Generic tablet that's available in two doses as well as an extended release form.
Pre-filled injection for diabetes that also helps you lose weight. Once a week treatment.
Generic type-2 diabetes tablet with a unique mode of action. The only licensed glitazone treatment.
Once-a-week injection for diabetes that can reduce your risk of cardiovascular disease.
If there’s a particular treatment or condition you’re looking for, tell us and we’ll look into it for you.
Submit your question here, or tell us if you’ve found an issue on our site.
We’ll get back to you very soon. We aim to respond to all queries in one working day.
You’re signed up to our newsletter. Keep an eye on your inbox for our latest update.